Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helene Pere

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2016
Hope in the Long Road Toward the Development of a Therapeutic Human Papillomavirus VaccineSoumaya Karaki, Helene Pere, Cecile Badoual, et al.
Oncoimmunology|July 30, 2013
Immunotherapy of HPV-associated head and neck cancer: Critical parametersMevyn Nizard, Federico Sandoval, Cecile Badoual, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 9, 2016
In Silico Adjuvant Design and ValidationMatthew N Davies, Helene Pere, Iris Bosschem, et al.
Head & Neck|March 2, 2010
Better understanding tumor-host interaction in head and neck cancer to improve the design and development of immunotherapeutic strategiesCécile Badoual, Federico Sandoval, Helene Pere, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 16, 2010
A decrease of regulatory T cells correlates with overall survival after sunitinib-based antiangiogenic therapy in metastatic renal cancer patientsOlivier Adotevi, Helene Pere, Patrice Ravel, et al.
Journal of Clinical Medicine Research|June 27, 2020
Purifying Selection in Human Immunodeficiency Virus-1 <i>pol</i> Gene in Perinatally Human Immunodeficiency Virus-1-Infected Children Harboring Discordant Immunological Response and Virological Nonresponse to Long-Term Antiretroviral TherapyRalph-Sydney Mboumba Bouassa, Helene Pere, Christian Diamant Mossoro-Kpinde, et al.
The American Journal of Surgical Pathology|July 28, 2023
Digital Papillary Adenocarcinoma in Nonacral Skin: Clinicopathologic and Genetic Characterization of 5 CasesThibault Kervarrec, Sandrine Imbeaud, David Veyer, et al.
Oncoimmunology|June 28, 2012
Comprehensive analysis of current approaches to inhibit regulatory T cells in cancerHelene Pere, Corinne Tanchot, Jagadeesh Bayry, et al.
Nature Immunology|September 2, 2021
Distinct systemic and mucosal immune responses during acute SARS-CoV-2 infectionNikaïa Smith, Pedro Goncalves, Bruno Charbit, et al.
Blood|September 13, 2011
A CCR4 antagonist combined with vaccines induces antigen-specific CD8+ T cells and tumor immunity against self antigensHelene Pere, Yves Montier, Jagadeesh Bayry, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2016
Hope in the Long Road Toward the Development of a Therapeutic Human Papillomavirus VaccineSoumaya Karaki, Helene Pere, Cecile Badoual, et al.
Oncoimmunology|July 30, 2013
Immunotherapy of HPV-associated head and neck cancer: Critical parametersMevyn Nizard, Federico Sandoval, Cecile Badoual, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 9, 2016
In Silico Adjuvant Design and ValidationMatthew N Davies, Helene Pere, Iris Bosschem, et al.
Head & Neck|March 2, 2010
Better understanding tumor-host interaction in head and neck cancer to improve the design and development of immunotherapeutic strategiesCécile Badoual, Federico Sandoval, Helene Pere, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 16, 2010
A decrease of regulatory T cells correlates with overall survival after sunitinib-based antiangiogenic therapy in metastatic renal cancer patientsOlivier Adotevi, Helene Pere, Patrice Ravel, et al.
Journal of Clinical Medicine Research|June 27, 2020
Purifying Selection in Human Immunodeficiency Virus-1 <i>pol</i> Gene in Perinatally Human Immunodeficiency Virus-1-Infected Children Harboring Discordant Immunological Response and Virological Nonresponse to Long-Term Antiretroviral TherapyRalph-Sydney Mboumba Bouassa, Helene Pere, Christian Diamant Mossoro-Kpinde, et al.
The American Journal of Surgical Pathology|July 28, 2023
Digital Papillary Adenocarcinoma in Nonacral Skin: Clinicopathologic and Genetic Characterization of 5 CasesThibault Kervarrec, Sandrine Imbeaud, David Veyer, et al.
Oncoimmunology|June 28, 2012
Comprehensive analysis of current approaches to inhibit regulatory T cells in cancerHelene Pere, Corinne Tanchot, Jagadeesh Bayry, et al.
Nature Immunology|September 2, 2021
Distinct systemic and mucosal immune responses during acute SARS-CoV-2 infectionNikaïa Smith, Pedro Goncalves, Bruno Charbit, et al.
Blood|September 13, 2011
A CCR4 antagonist combined with vaccines induces antigen-specific CD8+ T cells and tumor immunity against self antigensHelene Pere, Yves Montier, Jagadeesh Bayry, et al.
Pageof 2